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In this issue, Yu and colleagues [1] present a report on 
gene expression proﬁ   les of antigen (Bhsp65)-tolerized 
and preclinical arthritic rats with adjuvant-induced 
arthritis (AIA). AIA is a widely used animal model of 
rheumatoid arthritis, which is inducible in rats by 
immunization with Mycobacterium tuberculosis (Mtb) in 
complete Freund’s adjuvant [2]. It is a predominately CD4 
T cell-mediated chronic disease with clearly identi  ﬁ  able 
disease phases, including incubation, onset, peak, and 
recovery [3,4]. AIA has many features resembling 
rheumatoid arthritis; therefore, it has been extensively 
used for investigating the pathogenesis of rheumatoid 
arthritis and in preclinical studies. Th  e Mycobacterial 
65 kDa shock protein (Bhap65) has been identiﬁ  ed as an 
important disease-related antigen in AIA [4]. Pretreat  ment 
of rats with Bhsp65 protect them from AIA, provid  ing a 
good model for investigating immune tolerance [4,5].
In a ﬁ  rst step, Yu and colleagues investigated the gene 
expression proﬁ  les of lymph node (LN) cells of arthritic 
rats at diﬀ   erent clinical phases of AIA. Interestingly, 
compared with naive controls, maximal gene expression 
changes were observed in LN cells of rats in the 
incubation phase instead of the peak or recovery phases. 
Most diﬀ   erentially expressed genes at the incubation 
phase were upregulated, while most at the peak and 
recovery phases were downregulated. Th  is observation is 
consistent with ﬁ  ndings from a collagen-induced arthritis 
study in mouse [6], suggesting that immunological processes 
are active in the LN during this preclinical stage and that 
this process might be critical for arthritis development.
Aiming to identify the gene expression signature of 
Bhsp65-induced tolerance, Yu and colleagues further 
investigated the gene expression proﬁ   les of Bhsp65-
tolerized and preclinical arthritic rats. Th  ey observed 
only minor diﬀ  erences in the gene expression proﬁ  les of 
LN cells in the incubation phase between Bhsp65-
tolerized and preclinical arthritic rats. However, when 
they stimulated those cells with Bhsp65 in vitro, dramatic 
diﬀ  erences were observed between cells from Bhsp65-
tolerized and preclinical arthritic rats compared with 
unstimulated controls. By comparing the gene expression 
proﬁ  les of Bhsp65-tolerized rats and preclinical arthritic 
rats, 12 genes were identiﬁ   ed as encoding signature 
molecules of the Bhsp65-induced tolerance, including 
Cd86, Il1b, Lta, Socs3, Il10, Vegfa, Iﬁ  27l1, Il17a, Il17f,
Il22, Il33 and Cxcr7. Interestingly, 5 of those 12 signature 
molecules are Th  17 cell related. Il17a,  Il17f, and Il22
encode the signature cytokines of Th  17 cells [7], while 
proteins encoded by Socs3 and Il10 are essential negative 
regulators of Th   17 cells [8,9].
Since Il17a, Il17f and Il22 were upregulated in only the 
preclinical arthritic rats while Socs3 and Il10 were up-
regulated in only the Bhsp65-tolerized rats, it shows that 
there were strong Th   17 responses to in vitro stimulation 
with Bhsp65 in the preclinical arthritic group. Th  e  Th  17 
response to Bhsp65 is absent in the Bhsp65-tolerized 
group, and this absence might be due to the suppression of 
Th  17 negative regulators (Figure 1). In contrast to Th  17 
cell-related genes, the Th   1 and Th   2 cell-related genes Ifng
and Il4 behave diﬀ  erently, that is, Ifng is upregulated and 
Il4 is unchanged in both tolerized and preclinical arthritic 
groups. Th   ese results suggests that Th   17 cells might play a 
role in the breach of immune tolerance.
Th  17 cells are a recently identiﬁ   ed subset of CD4 
T cells, with a primary function of clearing extracellular 
pathogens during infections [7]. Although they have been 
recognized as key players in adaptive immunity, they 
Abstract
Th17 cells are thought to play a pathogenic role in 
various autoimmune diseases. Cytokines secreted by 
Th17 cells like IL-17, IL-17F and IL-22 have the capacity 
to mediate a massive infl  ammatory response. These 
proinfl  ammatroy cytokines are likely to mediate the 
pathogenic potential of Th17 cells. Recent evidence 
suggests a role for Th17 cells in the breach of immune 
tolerance. This might shed some new light on the 
pathogenic role of Th17 cells in autoimmunity.
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in 2005 [10,11]. Since then, extensive studies have been 
performed and conﬁ  rmed a pathogenic role of Th  17  cells 
in various autoimmune diseases and their animal models 
[7,12]. Nevertheless, the pathogenic characteristics of 
Th  17 cells in autoimmunity are only partially known. 
Studies have already shown that Th   17 cells secrete cyto-
kines, including IL-17, IL-17F and IL-22, and are able to 
mediate strong inﬂ  ammatory responses [7]. Th  ese pro-
inﬂ  am  matory cytokines could explain, at least partially, 
the pathogenic characteristics of Th  17 cells in auto-
immunity. However, whether other components contri-
bute to the pathogenic characteristics of Th   17 cells is not 
clear.
Recently, studies have investigated the role of Th  17 
cells in immune tolerance. In 2008, Wang and colleagues 
[13] reported that IL-17 could interfere with MBP 
68-86-induced immune tolerance in experimental 
autoimmune encephalomyelitis. In 2009, Satpute and 
colleagues [14] reported that Bhsp65-induced tolerance 
in AIA is associated with the reduction of IL-17 produc-
tion. More recently, Peron and colleagues [15] showed 
that oral tolerance is associated with Th   17 cell reduction 
in experimental autoimmune encephalomyelitis. Taken 
together, these studies suggest that Th   17 cells might play 
a role in the breach of immune tolerance, pointing to a 
new mechanism mediating their pathogenic role in 
autoimmunity. However, this needs to be validated and 
the mechanism behind it needs to be investigated further.
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Figure 1. Five Th17-related signature genes of Bhsp65-induced 
tolerance in adjuvant-induced arthritis. Upon stimulation 
with Bhsp65 on lymph node cells, genes indicated in yellow 
are upregulated in preclinical arthritic rats but not changed in 
Bhsp65-tolerized rats, while genes indicated in red are upregulated in 
Bhsp65-tolerized rats but not preclinical arthritic rats.
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